Vieworks Showcases X-ray Imaging Excellence: RSNA 2023 Spotligh

Vieworks, a renowned digital x-ray imaging solutions provider, is set to unveil pioneering advancements at RSNA 2023 in Chicago (Booth 1723, November 26th-29th). Building on the success of prior RSNA exhibitions, Vieworks will present its comprehensive range of DR flat panel detectors (FPDs) catering to general radiography, dynamic applications, and mammography. The focal point remains on the latest VIVIX-S F series, accompanied by the revolutionary VIVIX-S 1751S—a long-format detector tailored for imaging larger body parts and long bones.

The spotlight on the FDA-approved VIVIX-S F series persists, showcasing its glass-free TFT design, lightweight construction, and extended battery life, enhancing the imaging experience for practitioners. In response to industry demands for imaging larger body parts in fixed static DR applications, Vieworks expands its portfolio with the introduction of VIVIX-S 4747V, the largest single FPD, alongside the VIVIX-S 1751S, first showcased at ECR in March.

In harmony with its commitment to “Clearer Vision. Safer Imaging,” Vieworks introduces three groundbreaking software technologies at RSNA 2023. “Deep Denoising,” a deep learning-based technology, ensures imaging at the lowest radiation dose without compromising clarity or anatomical detail. “Bone Suppression,” seamlessly integrated into VXvue software, facilitates precise and safe diagnosis by delivering clear suppressed images without additional radiation exposure. The third innovation, an “AEC-embedded solution,” optimizes radiation levels for unparalleled image quality, highlighting a focus on safety and efficiency.

Seungki Hong, Vice President of Vieworks, conveyed his enthusiasm about the company’s participation in RSNA 2023. He emphasized Vieworks’ steadfast commitment to innovation, underlining how the VIVIX-S 1751S and the latest software technologies exemplify their dedication to advancing medical imaging. Additionally, he underscored Vieworks’ mission to establish new standards in imaging quality and safety, ensuring that practitioners have access to state-of-the-art solutions for precise diagnostics and patient care.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

LumiGuide, powered by Fiber Optic RealShape (FORS) technology, enables doctors to navigate through blood vessels using light, instead of X- ray. “[It’s] one of the most exciting changes that we’ve seen with imaging certainly throughout my career,” said Andres Schanzer, Vascular Surgeon, at UMass Memorial Medical Center, Worcester, MA, USA.
Carestream Health notes twenty-seven of the patents were awarded by the U.S. Patent and Trademark Office; an additional 43 patents were received in European and Asian countries.
According to an Insightec study, patients experienced significant reductions in upper limb tremor, tremor-related disability, and quality of life. The most common intraprocedural adverse events included dizziness, headache, nausea, and vomiting, which all resolved. Post-procedural adverse events included paraesthesia and gait disturbance, which were often transient or resolved within 12 months.
Chris Landon, Business Leader Image Guided Therapy Devices at Philips: “IVUS is a technology that has demonstrated an ability to both support safer procedures for patients and procedural staff alike including reductions in radiation exposure. As the global leader in IVUS solutions, we are grateful for the rigorous multidisciplinary approach to developing expert consensus on the value of IVUS and we look forward to working with all stakeholders to standardize the use of IVUS and reduce the barriers preventing utilization.”
"We are delighted to see our 3D solution CE-marked and available on the European market," says Ulrik Harrysson, CEO at SyntheticMR AB. "SyMRI 3D represents the next generation of quantitative MRI, offering unprecedented resolution and accuracy in brain imaging, revolutionizing the landscape of medical diagnostics."

By using this website you agree to accept Medical Device News Magazine Privacy Policy